Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Eurasian J Med ; 52(1): 1-5, 2020 Feb.
Article in English | MEDLINE | ID: mdl-32158304

ABSTRACT

OBJECTIVE: This retrospective study aimed to compare the clinical characteristics and trauma scores of Intensive Care Unit (ICU) trauma patients 65 years and older with the patients under 65 years old. MATERIALS AND METHODS: Trauma patients (n=161) who stayed at least 24 hours in ICU were included. Patients younger than 65 years were included into Group 1 (n=109) and patients aged ≥65 years (n=52) were included into Group 2. Patient characteristics and trauma index scores (GCS; APACHE II score, ISS; TRISS and RTS) at ICU admission were calculated. RESULTS: The patients in Group 2 had more comorbid disease compared with Group 1 (61.5%, 6.4%) (p=0.001). The Trauma-related Injury Severity Score score were higher in Group 1 (49.76±33.75) compared with Group 2 (35.38±34.93) (p=0.006). The APACHE II score were higher in Group 2 (20.08±7.60) compared with Group 1 (17.00±6.90) (p=0.007). The need for invasive mechanical ventilation and tracheostomy were more frequent in Group 2 trauma patients compared with those of patients in Group 1 (92.3%, 73.4%; p=0.003; 26.9%, 8.3%; p=0.002; respectively). The need for transfusion of packed red blood cell suspension (PRBC) was more frequent in Group 2 compared with Group 1 (92.3%, 55.0%; respectively) (p=0.001). The mortality rate was found to be higher in Group 2 compared with Group 1 (48.1%, 19.3%; respectively) (p=0.001). CONCLUSION: The elderly trauma patients have more comorbid disease, higher scores for APACHE II and lower scores for TRISS, more mechanical ventilation and tracheostomy requirements and higher mortality rate compared with young trauma patients.

2.
Urolithiasis ; 48(3): 235-244, 2020 Jun.
Article in English | MEDLINE | ID: mdl-30564847

ABSTRACT

The aim of this study was to investigate the efficacy of peritubular infiltration and ultrasound-guided low thoracal paravertebral block in patients undergoing percutaneous nephrolithotomy (PCNL). Sixty patients, American Society of Anesthesiologists I-II, between the ages of 18 and 65 years undergoing PCNL were randomized into three groups. Group peritubal infiltration (Pi, n = 20) received infiltration along the nephrostomy tube 20 ml 0.25% bupivacaine, in 6 and 12 o'clock position. Group paravertebral block (Pv, n = 20) received single-shot paravertebral block with 20 ml 0.25% bupivacaine at the level of T8-T9. Group control (C, n = 20): no intervention is performed. Postoperative opioid consumption and pain scores, opioid-related side effects, and additional analgesic requirement were recorded. The fentanyl consumption in Group Pv was significantly lower in comparison to Group C in all time intervals (p < 0.05). In the comparison of Group Pv and Group Pi, fentanyl consumptions in the postoperative 0-4th hours (100.00 ± 50.65 and 145.00 ± 61.55, respectively), 4-8th hours (50.00 ± 64.88 and 121.25 ± 56.93 respectively), and in the total of 24 h (197.50 ± 133.74 and 368.75 ± 116.66 respectively) were significantly lower in Group Pv (p < 0.05). The dynamic VAS scores analyzed at the 1st and 2nd hours were significantly lower in Group Pv than Group Pi (p < 0.05). Eight patients in Group C, two patients in Group Pi and 1 patient in Group Pv required additional analgesics and the difference was significant (p < 0.05). Paravertebral block achieved more effective analgesia by reducing postoperative opioid consumption and VAS scores comparison to the control and peritubal infiltration groups in patients undergoing percutaneous nephrolithotomy.


Subject(s)
Anesthetics, Local/administration & dosage , Bupivacaine/administration & dosage , Nephrolithotomy, Percutaneous , Nerve Block/methods , Ultrasonography, Interventional , Adolescent , Adult , Aged , Anesthesia, Local , Female , Humans , Male , Middle Aged , Prospective Studies , Young Adult
3.
World Neurosurg ; 129: e741-e748, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31201944

ABSTRACT

BACKGROUND: Neurogenic stunned myocardium (NSM) is a devastating complication of subarachnoid hemorrhage (SAH). The most widely accepted mechanism in the pathogenesis of NSM and takotsubo cardiomyopathy is catecholamine-mediated direct myocardial injury. The aim of this study is to examine if there is any effect of sympathetic overactivity of the stellate ganglions on myocardial tissues, secondary to vagal complex degeneration in SAH-induced NSM. MATERIALS AND METHODS: This study was conducted on 25 New Zealand female rabbits. After the examination, all animals were assigned into 3 groups randomly: a control group (n = 5), a sham group (n = 5), and a study group (n = 15) that was subjected to experimental SAH with double injection of blood into the cisterna magna. After 7 animals exhibited NSM, all animals were killed. Their brains, vagal complexes, stellate ganglions, and hearts were extracted and examined by histopathologic methods. Degenerated nodose ganglion neurons and stellate ganglion neuron densities were compared with degenerated myocardial tissue/normal myocardial tissue ratios, and the results were analyzed with the Mann-Whitney U test. RESULTS: Three rabbits in the study group died immediately after the second injection of blood. NSM developed in 7 animals after 1 to 5 days, which was diagnosed with transthoracic echocardiography. Interestingly, the animals that developed NSM had more stellate ganglia neurons and more degenerated neuron densities of nodose ganglia (P < 0.001). CONCLUSIONS: NSM and takotsubo cardiomyopathy may be induced by vagal complex degeneration and sympathetic overactivity, which originated from more neurons, including stellate ganglia and more degenerated neuron densities of nodose ganglia.


Subject(s)
Brain/pathology , Cardiomyopathies/pathology , Nerve Degeneration/pathology , Nodose Ganglion/pathology , Subarachnoid Hemorrhage/pathology , Vagus Nerve/pathology , Animals , Cardiomyopathies/etiology , Disease Models, Animal , Female , Nerve Degeneration/etiology , Neurons/pathology , Rabbits , Subarachnoid Hemorrhage/complications , Takotsubo Cardiomyopathy/etiology , Takotsubo Cardiomyopathy/pathology
4.
Braz J Anesthesiol ; 66(6): 583-593, 2016.
Article in English | MEDLINE | ID: mdl-27793233

ABSTRACT

This study was designed to investigate whether dexmedetomidine and thiopental have cerebral protective effects after focal cerebral ischemia in rats. Thirty male Sprague Dawley rats were randomly assigned to three groups: control group (Group C, n=10), dexmedetomidine group (Group D, n=10), thiopental group (Group T, n=10). After all rats were anesthetized, they were intubated, then mechanically ventilated. A catheter was inserted into the right femoral artery for continuous mean arterial pressure, physiological parameters and blood sampling at baseline, 5min after occlusion and 20min after reperfusion. A catheter was inserted into the left femoral vein for intravenous (IV) medication administration. Right common carotid artery of each rat was isolated and clamped for 45min. At the end of the duration common carotid artery were unclamped and the brain reperfusion was achieved for 90min. Dexmedetomidine was administered for Group D IV infusion, and Group T received thiopental IV. According to histopathologic scores cerebral ischemia was documented in all rats in Group C, but no ischemia was found in three rats in Group T and in four rats in Group D. Grade 3 cerebral ischemia was documented in three rats in Group C, and in only one rat in both groups T and D. For histopathologic grades the difference between Group T and Group D was not significant (p>0.05). But the differences between Group C and Group T (p<0.05) and Group C and Group D (p<0.01) were statically significant. In conclusion, we demonstrated that dexmedetomidine and thiopental have experimental histopathologic cerebral protective effects on experimental focal cerebral ischemia in rats.


Subject(s)
Brain Ischemia/prevention & control , Dexmedetomidine/therapeutic use , Hypnotics and Sedatives/therapeutic use , Neuroprotective Agents/therapeutic use , Thiopental/therapeutic use , Anesthesia , Animals , Brain Ischemia/pathology , Male , Rats , Rats, Sprague-Dawley , Reperfusion Injury/prevention & control , Respiration, Artificial
5.
Rev Bras Anestesiol ; 66(6): 583-593, 2016.
Article in Portuguese | MEDLINE | ID: mdl-27639507

ABSTRACT

This study was designed to investigate whether dexmedetomidine and thiopental have cerebral protective effects after focal cerebral ischemia in rats. Thirty male Sprague Dawley rats were randomly assigned to three groups: control group (Group C, n=10), dexmedetomidine group (Group D, n=10), thiopental group (Group T, n=10). After all rats were anesthetized, they were intubated, then mechanically ventilated. A catheter was inserted into the right femoral artery for continuous mean arterial pressure, physiological parameters and blood sampling at baseline, 5min after occlusion and 20min after reperfusion. A catheter was inserted into the left femoral vein for intravenous (IV) medication administration. Right common carotid artery of each rat was isolated and clamped for 45min. At the end of the duration common carotid artery were unclamped and the brain reperfusion was achieved for 90min. Dexmedetomidine was administered for Group D IV infusion, and Group T received thiopental IV. According to histopathologic scores cerebral ischemia was documented in all rats in Group C, but no ischemia was found in three rats in Group T and in four rats in Group D. Grade 3 cerebral ischemia was documented in three rats in Group C, and in only one rat in both groups T and D. For histopathologic grades the difference between Group T and Group D was not significant (p>0.05). But the differences between Group C and Group T (p<0.05) and Group C and Group D (p<0.01) were statically significant. In conclusion, we demonstrated that dexmedetomidine and thiopental have experimental histopathologic cerebral protective effects on experimental focal cerebral ischemia in rats.

6.
Eurasian J Med ; 47(2): 109-14, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26180495

ABSTRACT

OBJECTIVE: Pulmonary complications are important sepsis (such as ARDS, diffuse pneumonia). Acute respiratory distress syndrome (ARDS) is characterized by the extensive migration of neutrophils into alveoli of the lungs. Propofol and midazolam are the most widely used agents for sedation in intensive care units. Aimed to investigate the effects of anaesthesia with propofol and midazolam on measured hemodynamic variables and neutrophil migration induced by Escherichia Coli endotoxin (ECE) in pulmonary viscera. MATERIALS AND METHODS: Forty Sprague Dawley male rats were randomly assigned to four groups: Thiopental Sodium 30 mg/kg was administered intraperitoneally to anesthetize the rats. They were ventilated via tracheotomy. Femoral artery was cannulated for the measurement of continuous blood pressure and gases. Group C was the control. After the administration of 1 mL/kg 0.9% NaCL, infusion began at 1 mL/kg/h rate. In Group E 15 mg/kg lipopolysaccharide derived from ECE was administered iv. In Group PE, after a bolus dose of 10 mg/kg propofol and 15 mg/kg ECE, 10 mg/kg/h infusion was applied. In Group ME, after 0.1 mg/kg midazolam bolus dose and 15 mg/kg ECE administration, 0.1 mg/kg/h infusion was administered iv. Rats were sacrified by iv potassium chloride. The lungs were then removed, fixed in 10% buffered formalin for 3 days and embedded in paraffin. They were graded on a scale of 0-3 according to the aggregation of neutrophils. RESULTS: There was intense neutrophil migration in Group E (grade 2, 3). However, although mild neutrophil migration was obtained in 70% of the rat lungs in Group ME (grade 1, 2), it was recorded in only 30% of Group PE (grade 1). CONCLUSION: The sepsis model induced by ECE and compared with midazolam, propofol anaesthesia is associated with less neutrophil infiltration. In the light of the literature, propofol attenuate the free-radical-mediated lipid peroxidation and systemic inflammation in patients.

7.
Balkan Med J ; 30(4): 439-41, 2013 Dec.
Article in English | MEDLINE | ID: mdl-25207156

ABSTRACT

BACKGROUND: Mitral stenosis is the most important and common cardiac complication seen during pregnancy. Conception is discouraged in cases where pulmonary hypertension develops during the course of mitral stenosis. Successful general and regional anaesthetic interventions have been reported in some cases of severe pulmonary hypertension. CASE REPORTS: We present our experiences with anaesthetic management in two pregnant patients with pulmonary hypertension due to mitral valve stenosis. CONCLUSION: We preferred to continue spinal anaesthesia because gradually increasing the local anaesthetic dose during the procedure may minimise probable undesirable haemodynamic changes, such as hypotension and tachycardia.

8.
Paediatr Anaesth ; 18(9): 878-83, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18768048

ABSTRACT

BACKGROUND: Postoperative vomiting (POV) is a common complication after tonsillectomy. Dexamethasone is known to decrease postsurgical vomiting. In this study, we compared the effects of dexamethasone alone to dexamethasone plus propofol on postoperative vomiting in children undergoing tonsillectomy. METHODS: In a randomized double-blinded study, we evaluated 80 healthy children, aged 4-12 years, who underwent tonsillectomy with or without adenoidectomy. After anesthesia was induced by inhalation of sevoflurane, 0.15 mg x kg(-1) dexamethasone and 2 microg x kg(-1) fentanyl was administered i.v. to all patients. The patients in the dexamethasone plus propofol group received 1 mg x kg(-1) propofol before intubation and continuously after intubation at a rate of 20 microg x kg(-1) x min(-1) until the surgery was completed. Data for postoperative vomiting were grouped into the following time periods: 0-4 and 4-24 h. Data were analyzed using a Student's t-test and chi-squared analysis. RESULTS: The percentage of patients exhibiting a complete response (defined as no retching or vomiting for 24 h) increased from 37.5% in the dexamethasone-alone group to 75% in the dexamethasone plus propofol group (P = 0.001). Twenty-two patients (55%) in the dexamethasone-alone and nine patients (22.5%) in the dexamethasone plus propofol groups experienced vomited during 0-4 h (P = 0.003). Eight patients in the dexamethasone-alone group and three patients in the dexamethasone plus propofol group received ondansetron as a rescue antiemetic during the postoperative period. CONCLUSION: For children undergoing tonsillectomy, intraoperative subhypnotic propofol infusion combined with dexamethasone treatment provides a better prophylaxis against postoperative vomiting than does dexamethasone alone.


Subject(s)
Anesthetics, Intravenous/administration & dosage , Antiemetics/administration & dosage , Dexamethasone/administration & dosage , Postoperative Nausea and Vomiting/prevention & control , Propofol/administration & dosage , Tonsillectomy/adverse effects , Child , Child, Preschool , Double-Blind Method , Drug Therapy, Combination , Female , Humans , Male , Ondansetron/therapeutic use , Treatment Outcome
9.
Eurasian J Med ; 40(2): 98-101, 2008 Aug.
Article in English | MEDLINE | ID: mdl-25610039

ABSTRACT

The interscalene block technique is widely used for a variety of procedures on the upper extremities. In general, this technique is safe and effective but is not without hazards. A case of subdural block resulting from an interscalene block is presented. In a 60-year-old female patient with carpal tunnel syndrome, sudden bradycardia, unconsciousness and respiratory arrest developed within several minutes after performing the block. At the end of the postinjectional third hour, she regained full consciousness, spontaneous breathing and full sensorial functions, except for profound anesthesia in the right arm. Within 6.5 hours of injection, right arm strength and sensation returned to normal; however, analgesia remained until the postinjectional ninth hour.

10.
Int J Infect Dis ; 11(5): 446-9, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17331781

ABSTRACT

OBJECTIVE: Hydatid disease occurs throughout the world and is treated with both surgery and medical administration of albendazole. Some adverse effects of albendazole are known. However, its genotoxic effect on humans has not been reported yet. In this study, we aimed to investigate the genotoxic effect of albendazole on human lymphocytes in vivo. METHODS: The study involved 14 children (eight males and six females) who had undergone operations for hepatic hydatid disease. The ages of the patients ranged from 6 to 13 years. Genotoxicity of albendazole was evaluated as the frequency of sister chromatid exchange (SCE) and micronucleated cells in the patient's lymphocytes. Prior to and after albendazole treatment, blood samples were obtained from these patients for SCE and micronucleus (MN) studies. SCE and MN frequencies of the patients were measured separately before and after albendazole treatment. RESULTS: All patient SCE values increased significantly after albendazole administration (p<0.001). Similarly, MN frequencies in all the patients increased significantly following albendazole treatment (p<0.001). CONCLUSION: This study revealed that both SCE and MN frequencies are higher after albendazole treatment. The results suggest that albendazole may be genotoxic to human lymphocytes in vivo.


Subject(s)
Albendazole/adverse effects , Anthelmintics/adverse effects , Echinococcosis, Hepatic/drug therapy , Lymphocytes/drug effects , Micronuclei, Chromosome-Defective/chemically induced , Sister Chromatid Exchange/drug effects , Adolescent , Albendazole/administration & dosage , Animals , Anthelmintics/administration & dosage , Child , Echinococcosis/blood , Echinococcosis/drug therapy , Echinococcosis/surgery , Echinococcosis, Hepatic/blood , Echinococcosis, Hepatic/parasitology , Echinococcosis, Hepatic/surgery , Echinococcus , Female , Humans , Male
11.
Saudi Med J ; 26(9): 1424-8, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16155662

ABSTRACT

OBJECTIVE: We compared the postischemic cerebral protective effects of sevoflurane and desflurane in rats with incomplete cerebral ischemia. METHODS: This study was performed in Ataturk University Medical Faculty in Erzurum, Turkey in 2003. All rats were anesthetized with 5% isoflurane, intubated and mechanically ventilated, then given 2% isoflurane in 70% nitrous oxide and 30% O2. The femoral artery was cannulated. Five minutes before ischemia, and at the end of ischemia, arterial blood was taken for plasma glucose, hematocrit and blood gas analysis. Hypotension was induced by hemorrhage, and then both common carotid arteries were clamped for 10 minutes. In the control group, the arteries were then unclamped and the rats were extubated. In the other 2 groups, isoflurane was discontinued after carotid artery unclamping, and either 2% sevoflurane or 6% desflurane in 70% nitrous oxide and 30% O2 was given for 30 minutes, after which the rats were extubated. Five days later, they were sacrificed, and histological scores in CA1 were graded on a scale 0-3. RESULTS: Histopathological outcome in sevoflurane and desflurane group was not different, but there were differences between sevoflurane and control (p<0.05), and desflurane and control (p<0.01). CONCLUSION: These data indicate that sevoflurane and desflurane have cerebral protective effects when given after ischemia.


Subject(s)
Anesthetics, Inhalation/administration & dosage , Brain Ischemia/pathology , Brain Ischemia/prevention & control , Isoflurane/analogs & derivatives , Methyl Ethers/administration & dosage , Neuroprotective Agents/administration & dosage , Analysis of Variance , Animals , Biopsy, Needle , Cerebrovascular Circulation/drug effects , Desflurane , Disease Models, Animal , Immunohistochemistry , Isoflurane/administration & dosage , Male , Probability , Random Allocation , Rats , Rats, Sprague-Dawley , Reference Values , Risk Factors , Sevoflurane
12.
Can J Physiol Pharmacol ; 82(7): 502-5, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15389297

ABSTRACT

Analgesics are commonly injected intra-articularly for analgesia after arthroscopic surgery, especially of knee joints. The aim of this study was to research the effects of ketorolac and morphine on articular cartilage and synovial membrane. This study used rabbit right and left hind knee joints. The treatments, saline, morphine, or ketorolac, were administered intra-articularly 24 h after injection, and 5 joints from animals in each drug group were chosen randomly to form Group I and subgroups of Group I. The same procedures were applied after 48 h and 10 days of injection to form Groups II and III, respectively, and subgroups of these groups. Knee joints were excised and a blinded observer evaluated the histopathology according to inflammation of the articular cartilage, inflammatory cell infiltration, hypertrophy, and hyperplasia of the synovial membrane. No histopathological changes were found in the control groups. In the ketorolac and morphine groups, there were varying degrees of synovial membrane inflammatory cell infiltration and minimal, mild, or moderate synovial membrane cell hyperplasia or hypertrophy. Except for the ketorolac group at 24 h, both ketorolac and morphine groups showed more histopathological changes than controls (p < 0.05). Morphine and ketorolac both cause mild histopathological changes in rabbit knee joints, morphine causing more than ketorolac, but both of the drugs can be used intra-articularly with safety.


Subject(s)
Analgesics, Opioid/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Cartilage, Articular/drug effects , Ketorolac/adverse effects , Morphine/adverse effects , Synovial Membrane/drug effects , Analgesics, Opioid/administration & dosage , Animals , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Cartilage, Articular/pathology , Inflammation/chemically induced , Inflammation/pathology , Injections, Intra-Articular , Ketorolac/administration & dosage , Knee Joint/drug effects , Knee Joint/pathology , Male , Morphine/administration & dosage , Osteochondritis/chemically induced , Osteochondritis/pathology , Rabbits , Synovial Membrane/pathology , Synovitis/chemically induced , Synovitis/pathology
13.
Anesth Analg ; 98(4): 1062-1065, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15041599

ABSTRACT

UNLABELLED: We studied the effect of intraarticular saline, sufentanil, or sufentanil plus methylprednisolone after knee arthroscopic meniscectomy. In a double-blind randomized study, 60 patients undergoing knee arthroscopic meniscectomy were allocated to groups receiving intraarticular saline, intraarticular sufentanil 10 microg, or sufentanil 10 microg plus methylprednisolone 40 mg at the end of arthroscopy during general anesthesia. Postoperatively, pain levels at rest and during movement (i.e., active flexion of the knee) were measured by a visual analog scale and were significantly decreased in the sufentanil and sufentanil plus methylprednisolone groups compared with the control group. Moreover, we found that there was a significant reduction in intraarticular sufentanil and sufentanil plus methylprednisolone in the postoperative consumption of analgesics. We also found that the use of intraarticular sufentanil or sufentanil plus methylprednisolone after knee arthroscopic meniscectomy decreases the amount of supplementary analgesic needed for pain relief during the early postoperative period. In addition, we detected that sufentanil provided prolonged pain relief up to 24 h when compared with control, whereas when we combined sufentanil plus methylprednisolone, we found that it further reduced pain and use of analgesics when compared with sufentanil. IMPLICATIONS: The combined use of intraarticular sufentanil (10 microg) and methylprednisolone (40 mg) in arthroscopic meniscectomy surgery reduced both postoperative pain scores and the use of additional analgesics.


Subject(s)
Analgesics, Opioid/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Arthroscopy , Knee/surgery , Methylprednisolone/therapeutic use , Pain, Postoperative/drug therapy , Sufentanil/therapeutic use , Adult , Analgesics, Opioid/administration & dosage , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Double-Blind Method , Drug Therapy, Combination , Female , Humans , Injections, Intra-Articular , Male , Methylprednisolone/administration & dosage , Pain Measurement , Sufentanil/administration & dosage , Tourniquets
SELECTION OF CITATIONS
SEARCH DETAIL
...